DE2521113A1 - Cycloaliphatische derivate von 3.3-diphenylpropylamin - Google Patents
Cycloaliphatische derivate von 3.3-diphenylpropylaminInfo
- Publication number
- DE2521113A1 DE2521113A1 DE19752521113 DE2521113A DE2521113A1 DE 2521113 A1 DE2521113 A1 DE 2521113A1 DE 19752521113 DE19752521113 DE 19752521113 DE 2521113 A DE2521113 A DE 2521113A DE 2521113 A1 DE2521113 A1 DE 2521113A1
- Authority
- DE
- Germany
- Prior art keywords
- compounds according
- diphenylpropylamine
- meaning
- hydrochloride
- general formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT2270974 | 1974-05-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
DE2521113A1 true DE2521113A1 (de) | 1976-03-18 |
Family
ID=11199496
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE19752521113 Withdrawn DE2521113A1 (de) | 1974-05-15 | 1975-05-13 | Cycloaliphatische derivate von 3.3-diphenylpropylamin |
Country Status (4)
Country | Link |
---|---|
JP (1) | JPS5123248A (ru) |
DE (1) | DE2521113A1 (ru) |
FR (1) | FR2270853B1 (ru) |
GB (1) | GB1461240A (ru) |
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004017964A1 (en) | 2002-08-19 | 2004-03-04 | Pfizer Products Inc. | Combination therapy for hyperproliferative diseases |
US7056906B2 (en) | 2001-09-21 | 2006-06-06 | Schering Corporation | Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women |
WO2007062314A2 (en) | 2005-11-23 | 2007-05-31 | Bristol-Myers Squibb Company | Heterocyclic cetp inhibitors |
WO2008070496A2 (en) | 2006-12-01 | 2008-06-12 | Bristol-Myers Squibb Company | N- ( (3-benzyl) -2, 2- (bis-phenyl) -propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases |
US7732413B2 (en) | 2003-03-07 | 2010-06-08 | Schering Corporation | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
US7741289B2 (en) | 2003-03-07 | 2010-06-22 | Schering Corporation | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
WO2011069038A2 (en) | 2009-12-03 | 2011-06-09 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
EP2392567A1 (en) | 2005-10-21 | 2011-12-07 | Bristol-Myers Squibb Company | Benzothiazine derivatives and their use as lxr modulators |
WO2013138352A1 (en) | 2012-03-15 | 2013-09-19 | Synergy Pharmaceuticals Inc. | Formulations of guanylate cyclase c agonists and methods of use |
WO2014151206A1 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
WO2014151200A2 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Compositions useful for the treatment of gastrointestinal disorders |
WO2014170786A1 (en) | 2013-04-17 | 2014-10-23 | Pfizer Inc. | N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases |
EP2810951A2 (en) | 2008-06-04 | 2014-12-10 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
WO2014197720A2 (en) | 2013-06-05 | 2014-12-11 | Synergy Pharmaceuticals, Inc. | Ultra-pure agonists of guanylate cyclase c, method of making and using same |
EP2998314A1 (en) | 2007-06-04 | 2016-03-23 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
WO2016055901A1 (en) | 2014-10-08 | 2016-04-14 | Pfizer Inc. | Substituted amide compounds |
WO2020150473A2 (en) | 2019-01-18 | 2020-07-23 | Dogma Therapeutics, Inc. | Pcsk9 inhibitors and methods of use thereof |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2482956A1 (fr) * | 1980-05-22 | 1981-11-27 | Synthelabo | Cyclohexylalkylamines, leurs procedes de preparation et leur application en therapeutique |
-
1975
- 1975-05-13 DE DE19752521113 patent/DE2521113A1/de not_active Withdrawn
- 1975-05-14 GB GB2041575A patent/GB1461240A/en not_active Expired
- 1975-05-14 JP JP5621775A patent/JPS5123248A/ja active Pending
- 1975-05-15 FR FR7515190A patent/FR2270853B1/fr not_active Expired
Cited By (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7056906B2 (en) | 2001-09-21 | 2006-06-06 | Schering Corporation | Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women |
WO2004017964A1 (en) | 2002-08-19 | 2004-03-04 | Pfizer Products Inc. | Combination therapy for hyperproliferative diseases |
US7732413B2 (en) | 2003-03-07 | 2010-06-08 | Schering Corporation | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
US7741289B2 (en) | 2003-03-07 | 2010-06-22 | Schering Corporation | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
EP2392567A1 (en) | 2005-10-21 | 2011-12-07 | Bristol-Myers Squibb Company | Benzothiazine derivatives and their use as lxr modulators |
WO2007062314A2 (en) | 2005-11-23 | 2007-05-31 | Bristol-Myers Squibb Company | Heterocyclic cetp inhibitors |
WO2008070496A2 (en) | 2006-12-01 | 2008-06-12 | Bristol-Myers Squibb Company | N- ( (3-benzyl) -2, 2- (bis-phenyl) -propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases |
EP2998314A1 (en) | 2007-06-04 | 2016-03-23 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
EP2810951A2 (en) | 2008-06-04 | 2014-12-10 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
EP2923706A1 (en) | 2009-12-03 | 2015-09-30 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia |
WO2011069038A2 (en) | 2009-12-03 | 2011-06-09 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
WO2013138352A1 (en) | 2012-03-15 | 2013-09-19 | Synergy Pharmaceuticals Inc. | Formulations of guanylate cyclase c agonists and methods of use |
EP3708179A1 (en) | 2012-03-15 | 2020-09-16 | Bausch Health Ireland Limited | Formulations of guanylate cyclase c agonists and methods of use |
EP4309673A2 (en) | 2012-03-15 | 2024-01-24 | Bausch Health Ireland Limited | Formulations of guanylate cyclase c agonists and methods of use |
WO2014151206A1 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
WO2014151200A2 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Compositions useful for the treatment of gastrointestinal disorders |
WO2014170786A1 (en) | 2013-04-17 | 2014-10-23 | Pfizer Inc. | N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases |
WO2014197720A2 (en) | 2013-06-05 | 2014-12-11 | Synergy Pharmaceuticals, Inc. | Ultra-pure agonists of guanylate cyclase c, method of making and using same |
WO2016055901A1 (en) | 2014-10-08 | 2016-04-14 | Pfizer Inc. | Substituted amide compounds |
WO2020150473A2 (en) | 2019-01-18 | 2020-07-23 | Dogma Therapeutics, Inc. | Pcsk9 inhibitors and methods of use thereof |
Also Published As
Publication number | Publication date |
---|---|
FR2270853A1 (ru) | 1975-12-12 |
GB1461240A (en) | 1977-01-13 |
FR2270853B1 (ru) | 1978-09-08 |
JPS5123248A (en) | 1976-02-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE2521113A1 (de) | Cycloaliphatische derivate von 3.3-diphenylpropylamin | |
DE1620704A1 (de) | Verfahren zur Herstellung von Indolizinverbindungen | |
DE2227022C2 (de) | Hexamethylendiamin-Verbindungen und deren Verwendung | |
DE1103342B (de) | Verfahren zur Herstellung neuer 1, 2-Diphenyl-3, 5-dioxo-1, 2, 4-triazolidin-Derivate | |
CH441291A (de) | Verfahren zur Herstellung von organischen Aminen | |
AT238180B (de) | Verfahren zur Herstellung neuer Pyrrolidinverbindungen | |
AT339277B (de) | Verfahren zur herstellung von neuen 11-amino-benzo(b) bicyclo (3,3,1)nona-3,6a(10a)dienen und deren saureadditionssalzen | |
DE1595903C (de) | 1-Substituierte 2,6-Dimethyl-4-phenylpiperazine | |
AT238186B (de) | Verfahren zur Herstellung neuer Pyrrolidinverbindungen | |
DE2058237C (ru) | ||
AT256823B (de) | Verfahren zur Herstellung von neuen heterocyclischen Benzamidoverbindungen und ihren Salzen | |
AT219583B (de) | Verfahren zur Herstellung von disubstituierten Carbonsäurehydraziden | |
AT274788B (de) | Verfahren zur Herstellung von neuen N-(Hydroxycyclohexyl)-halogen-aminobenzylaminen und deren Säureadditionssalzen | |
AT251559B (de) | Verfahren zur Herstellung von neuen Phenylisopropylaminen und deren Salzen | |
AT272301B (de) | Verfahren zur Herstellung von neuen basischen, tricyclischen Verbindungen und deren Salzen | |
AT213890B (de) | Verfahren zur Herstellung neuer 3,5-Dioxo-1,2,4-triazolidine | |
AT206890B (de) | Verfahren zur Herstellung von neuen tertiären Aminen | |
DE1518549A1 (de) | Verfahren zur Herstellung neuer Phenylcyclohexylalkylamine und ihrer Salze | |
AT221087B (de) | Verfahren zur Herstellung neuer, basischer Indol-Derivate | |
AT210435B (de) | Verfahren zur Herstellung von neuen Ferrocenderivaten | |
AT201580B (de) | Verfahren zur Herstellung neuer, sekundärer Amine | |
AT266075B (de) | Verfahren zur Herstellung von neuen Sulfonaniliden und deren Säureadditions- und Metallsalzen | |
AT226710B (de) | Verfahren zur Herstellung von neuen Dihydrochinoxalonen-(2) und von deren Salzen | |
AT219577B (de) | Verfahren zur Herstellung von neuen Triaminen und deren salzartigen Abkömmlingen | |
AT334883B (de) | Verfahren zur herstellung von neuen alfa-(1-bis-arylalkylaminoalkyl)-aralkoxybenzylalkoholen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8110 | Request for examination paragraph 44 | ||
8115 | Request for examination void | ||
8110 | Request for examination paragraph 44 | ||
8139 | Disposal/non-payment of the annual fee |